1. Home
  2. KMT vs DYN Comparison

KMT vs DYN Comparison

Compare KMT & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kennametal Inc.

KMT

Kennametal Inc.

HOLD

Current Price

$27.54

Market Cap

2.1B

Sector

Industrials

ML Signal

HOLD

DYN

Dyne Therapeutics Inc.

HOLD

Current Price

$22.25

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KMT
DYN
Founded
1938
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.9B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
KMT
DYN
Price
$27.54
$22.25
Analyst Decision
Hold
Strong Buy
Analyst Count
6
15
Target Price
$25.83
$36.53
AVG Volume (30 Days)
999.1K
2.6M
Earning Date
11-05-2025
11-05-2025
Dividend Yield
2.89%
N/A
EPS Growth
N/A
N/A
EPS
1.22
N/A
Revenue
$1,982,871,000.00
N/A
Revenue This Year
$2.40
N/A
Revenue Next Year
$3.62
N/A
P/E Ratio
$22.68
N/A
Revenue Growth
N/A
N/A
52 Week Low
$17.30
$6.36
52 Week High
$29.15
$31.29

Technical Indicators

Market Signals
Indicator
KMT
DYN
Relative Strength Index (RSI) 67.34 61.55
Support Level $25.23 $20.44
Resistance Level $28.25 $22.27
Average True Range (ATR) 0.85 1.50
MACD 0.02 -0.00
Stochastic Oscillator 71.56 98.32

Price Performance

Historical Comparison
KMT
DYN

About KMT Kennametal Inc.

Kennametal Inc is a manufacturer of metalworking tools and wear-resistant engineered components and coatings. The company operates in two business segments; Metal Cutting and Infrastructure. It generates maximum revenue from the Metal Cutting segment. The Metal Cutting segment develops and manufactures high-performance tooling and metal cutting products and services and offers an assortment of standard and custom metal cutting solutions to diverse end markets, including aerospace, general engineering, energy, and transportation. Geographically, it derives maximum revenue from the United States and the rest from Germany, China, Canada, India, Italy, and other countries.

About DYN Dyne Therapeutics Inc.

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.

Share on Social Networks: